Exchange: NASDAQ·Updated 07:15 AM EDT
DRMA logo

DRMA Dermata Therapeutics Inc

$1.30
$0.00
(0.00%)
Pre-Market
Prev Close $1.30
Reported EarningsAug 11
Mkt Cap$5.23M
Vol168.00

About DRMA

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.
46

Neutral Sentiment

How do you feel about DRMA?

Advertisement|Remove ads.